Is that guy jorge still at GGII? bwahahaha

Whoa look at JANE walking down the ask

I think she can break 16 today

Ran from .002's to .02 in less than a week. This could pull back pretty steep

Aint chu like the #1 GGII fan like 2 years ago? You should know everything bwahahaha

Nahhhhh its too high now

Have a good weekend everybody! See you next week at $15+

I am so excited for next week. This thing is gonna be the #1 runner of next week.

A cherry on the top would be Cohen filing another 13G for more shares bought. He's got a 8% stake but its still peanuts for him. Maybe he wants to own half the company eventually. Remember we have $60M cash and little to no debt. Market cap is still trading well under cash on hand

A lot of people shorted this. After hours short covering could drive this to over $12. With a 5m O/S market cap is just $50m for a drug that could be worth hundreds of millions.

Next level is $12.00! Shorts are going to get crushed over the weekend. I think this opens up around $11-12 and then break $12 and its gonna get juicy we could see $20+ imo

There it goes! This thing is gonna go crazy!

This thing is like a rocket fueling up getting ready to launch. $10 break is the key range. 30 minutes left before close i think she closes near HOD

Look at that strong bounce off of 9.00 support. I think we see a close over 10. This is one of the strongest biotechs today in a down market.

Next resistance is about $12 and then after that its smooth sailing to $16-$17-$20 and up

This is the most clean textbook chart trading i've seen lately. Higher highs and higher lows. Someone is slowly loading here. Shorts might get trapped overnight and this might just gap up to $15 next week

The malmalcita GGII still going. Im not in it but gahhhhhhhhhh damnnnnnn bwahahahahaha

Break open 10 again and we might see 12-15 easy

What's goin on wit that thing? I remember they were making weed cigs or something and you were their #1 fan bwahahahhahaha

GAHHHHH damn your boy GGII is up again today

Any news out today? Volume just spiked up

Remember the POS GGII? Thats your boy right there running now lol

$60M in cash, no debt, 5 mil O/S, half of the float is held by institutions and insiders, I think this could see a lot higher.

8% stake is just a starter, i bet he's buying all week in small amounts here and there. The chart looks like someone is slowly loading shares on both on the supports and resistances.

This is a $20+ stock in the making

Your bff GGII is going choooo choooo bwahahahha im not in it but i thought it was funny bwahahahhaa

Remember your old friend and #1 runna stunna GGII? It's running now bwahahahahaha

XCPL Merger by end of August?

https://www.otcmarkets.com/stock/XCPL/news/XCPCNL-Business-Services-Announces-Signing-of-Reverse-Merger-Acquisition-Agreements-with-Centiment-Capital-Holdings?id=368840

XCPL Merger by end of August?

https://www.otcmarkets.com/stock/XCPL/news/XCPCNL-Business-Services-Announces-Signing-of-Reverse-Merger-Acquisition-Agreements-with-Centiment-Capital-Holdings?id=368840

Minerva Neurosciences rises 75% after Steven Cohen firm discloses large stake

Minerva Neurosciences (NASDAQ:NERV) is up 75% in Wednesday afternoon trading following an SEC filing stating that Point72 Capital Advisors has an 8.8% stake in the company.
The company reached a high today of $8.58 per share, though that is still well below the 52-week high of $16.80.
The filing, posted after Tuesday's closing bell, states that Point72 has 470K outstanding shares.
Steven A. Cohen is founder of Point72.
Minerva (NERV) is focused on treatments for central nervous system diseases. Its lead candidate, roluperidone, is in phase 3 for schizophrenia.
Seeking Alpha's Quant Rating views Minerva (NERV) as a hold with strong grades for revisions and momentum.

https://seekingalpha.com/news/3876248-minerva-neurosciences-rises-42-after-steven-cohen-firm-takes-large-stake

Minerva Neurosciences rises 75% after Steven Cohen firm discloses large stake

Minerva Neurosciences (NASDAQ:NERV) is up 75% in Wednesday afternoon trading following an SEC filing stating that Point72 Capital Advisors has an 8.8% stake in the company.
The company reached a high today of $8.58 per share, though that is still well below the 52-week high of $16.80.
The filing, posted after Tuesday's closing bell, states that Point72 has 470K outstanding shares.
Steven A. Cohen is founder of Point72.
Minerva (NERV) is focused on treatments for central nervous system diseases. Its lead candidate, roluperidone, is in phase 3 for schizophrenia.
Seeking Alpha's Quant Rating views Minerva (NERV) as a hold with strong grades for revisions and momentum.

https://seekingalpha.com/news/3876248-minerva-neurosciences-rises-42-after-steven-cohen-firm-takes-large-stake

That's true

$NERV 5 mil O/S $40m market cap. Hedge funds just took a 8% stake. Market cap is trading less than the company's cash on hand. NDA just submitted for its drug. Chart is pointing at a run above $12 if momentum continues.

$NERV 5 mil O/S $40m market cap. Hedge funds just took a 8% stake. Market cap is trading less than the company's cash on hand. NDA just submitted for its drug. Chart is pointing at a run above $12 if momentum continues.

Things like this is what makes me think about never buying a OTC again. Lol

What a POS market lol

Time to go into hibernation again right chivito? Every runner OTC gets it dumps hard. This is why people stay away from OTC now. What a shame

That's a diluted POS 12 billion shares

Market was good for 2 weeks and then dumpy dumpy chivipoopoo lol

MLFB YUUUUUUUUUUUUGE HITS